BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24069258)

  • 21. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction.
    Tan Z; Lei Y; Xu J; Shi S; Hua J; Zhang B; Meng Q; Liu J; Zhang Y; Wei M; Yu X; Liang C
    Aging (Albany NY); 2020 Nov; 12(23):24228-24241. PubMed ID: 33226369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
    Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
    Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
    Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
    Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients.
    Gentiluomo M; Puchalt García P; Galeotti AA; Talar-Wojnarowska R; Tjaden C; Tavano F; Strobel O; Kupcinskas J; Neoptolemos J; Hegyi P; Costello E; Pezzilli R; Sperti C; Lawlor RT; Capurso G; Szentesi A; Soucek P; Vodicka P; Lovecek M; Hackert T; Cavestro GM; Milanetto AC; Canzian F; Campa D
    Carcinogenesis; 2019 Jun; 40(4):544-550. PubMed ID: 30629142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
    Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
    PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
    Cao B; Jia J; Ma L; Di L; Song G; Yuan Y; Ma B; Zhu Y; Yu J; Wang X; Zhou X; Lyerly HK; Ren J
    Clin Transl Oncol; 2012 Aug; 14(8):575-85. PubMed ID: 22855139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
    Murota Y; Tabu K; Taga T
    BMC Cancer; 2016 Nov; 16(1):847. PubMed ID: 27814696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
    Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
    J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.
    Fujiwara S; Saiki Y; Ishizawa K; Fukushige S; Yamanaka M; Sato M; Ishida M; Motoi F; Unno M; Horii A
    Cancer Med; 2019 Apr; 8(4):1671-1678. PubMed ID: 30791220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.